Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Doximity (DOCS) to $70 from $81 and keeps an Outperform rating on the shares. The company reported a “strong” Q2, but pull-forward tempers second half growth, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Balanced Outlook on Doximity: Strong Performance Meets Conservative Guidance
- Doximity Reports Strong Q2 Growth and AI Expansion
- Closing Bell Movers: Expedia up 15%, Affirm up 12% on earnings beats
- Doximity’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Doximity raises FY26 revenue view to $640M-$646M from $628M-$636M